These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 7542523)
21. [Preparation of a specific immunogen based on bacteriophage M13]. Minenkova OO; Il'ichev AA; Kishchenko GP; Il'icheva TN; Khripin IuL; Oreshkova SF; Petrenko VA Mol Biol (Mosk); 1993; 27(3):561-8. PubMed ID: 7686250 [TBL] [Abstract][Full Text] [Related]
22. Gag-derived proteins of HIV-1 isolates from Indian patients: cloning, expression, and purification of p17 of B- and C-subtypes. Gupta S; Arora K; Gupta A; Chaudhary VK Protein Expr Purif; 2001 Apr; 21(3):378-85. PubMed ID: 11281711 [TBL] [Abstract][Full Text] [Related]
23. Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model. Earl PL; Wyatt LS; Montefiori DC; Bilska M; Woodward R; Markham PD; Malley JD; Vogel TU; Allen TM; Watkins DI; Miller N; Moss B Virology; 2002 Mar; 294(2):270-81. PubMed ID: 12009868 [TBL] [Abstract][Full Text] [Related]
24. A peptide library expressed in yeast reveals new major epitopes from human immunodeficiency virus type 1. Madaule P; Gairin JE; Bénichou S; Rossier J FEMS Microbiol Immunol; 1991 Apr; 3(2):99-107. PubMed ID: 1713777 [TBL] [Abstract][Full Text] [Related]
25. Construction and characterization of recombinant VLPs and Semliki-Forest virus live vectors for comparative evaluation in the SHIV monkey model. Notka F; Stahl-Hennig C; Dittmer U; Wolf H; Wagner R Biol Chem; 1999 Mar; 380(3):341-52. PubMed ID: 10223337 [TBL] [Abstract][Full Text] [Related]
26. Oligomeric nature of transmembrane glycoproteins of HIV-2: procedures for their efficient dissociation and preparation of Western blots for diagnosis. Parekh BS; Pau CP; Granade TC; Rayfield M; De Cock KM; Gayle H; Schochetman G; George JR AIDS; 1991 Aug; 5(8):1009-13. PubMed ID: 1777159 [TBL] [Abstract][Full Text] [Related]
27. [Production of recombinant proteins and their use in immunoblotting]. Farkhutdinov MR; Galiullin FG; Davletov EG; Gabbasov ShF; Safin BN Vopr Med Khim; 1993; 39(3):60-2. PubMed ID: 8333196 [TBL] [Abstract][Full Text] [Related]
28. The envelope of HIV-1 as a key component to infectivity. Buchbinder A Prog AIDS Pathol; 1990; 2():1-11. PubMed ID: 2103853 [No Abstract] [Full Text] [Related]
29. Chimeric HIV-1 virus-like particles containing gp120 epitopes as a result of a ribosomal frameshift elicit Gag- and SU-specific murine cytotoxic T-lymphocyte activities. Tobin GJ; Li GH; Fong SE; Nagashima K; Gonda MA Virology; 1997 Sep; 236(2):307-15. PubMed ID: 9325238 [TBL] [Abstract][Full Text] [Related]
30. Influence of MA internal sequences, but not of the myristylated N-terminus sequence, on the budding site of HIV-1 Gag protein. Gallina A; Mantoan G; Rindi G; Milanesi G Biochem Biophys Res Commun; 1994 Nov; 204(3):1031-8. PubMed ID: 7980574 [TBL] [Abstract][Full Text] [Related]
31. The use of a chimera HIV-1/HIV-2 envelope protein for immunodiagnosis of HIV infection: its expression and purification in E. coli by use of a translation initiation site within HIV-1 env gene. Han B; Meng L; Song X; Chen Q; Wang H; Ling S; Ma X Biochem Mol Biol Int; 1998 Oct; 46(3):607-17. PubMed ID: 9818100 [TBL] [Abstract][Full Text] [Related]
32. Characterization of gag and pol sequences from long-term survivors of human immunodeficiency virus type 1 infection. Huang Y; Zhang L; Ho DD Virology; 1998 Jan; 240(1):36-49. PubMed ID: 9448687 [TBL] [Abstract][Full Text] [Related]
33. Generation and analysis of vaccinia virus recombinants. Mazzara GP; Destree A; Mahr A Methods Enzymol; 1993; 217():557-81. PubMed ID: 8474351 [No Abstract] [Full Text] [Related]
34. Insertion of a short human immunodeficiency virus (HIV)-2 gp36 sequence into an HIV-1 p24 recombinant protein results in a polypeptide with potent and TCRBV-restricted T cell triggering activity. Imberti L; Sottini A; Quiròs Roldan E; Albertini A; Mattioli S; Prati E; Primi D Eur J Immunol; 1995 Jan; 25(1):218-25. PubMed ID: 7843234 [TBL] [Abstract][Full Text] [Related]
35. Overexpression and purification of human immunodeficiency virus type 1 env derived epitopes in Escherichia coli. Sohn MJ; Lee ME; Park HS; Nham SU; Lee YI J Biotechnol; 1996 Mar; 45(3):211-6. PubMed ID: 8721306 [TBL] [Abstract][Full Text] [Related]
36. Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies. Luo L; Li Y; Cannon PM; Kim S; Kang CY Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10527-31. PubMed ID: 1438241 [TBL] [Abstract][Full Text] [Related]
37. Expression of human immunodeficiency virus genes using baculovirus expression system. Kang CY Mol Biotechnol; 1997 Oct; 8(2):173-87. PubMed ID: 9406188 [TBL] [Abstract][Full Text] [Related]
38. Construction of recombinant extended single-chain antibody peptide conjugates for use in the diagnosis of HIV-1 and HIV-2. Coia G; Hudson PJ; Lilley GG J Immunol Methods; 1996 Jun; 192(1-2):13-23. PubMed ID: 8699008 [TBL] [Abstract][Full Text] [Related]
39. Expression in yeast of a cDNA clone encoding a transmembrane glycoprotein gp41 fragment (a.a. 591-642) bearing the major immunodominant domain of human immunodeficiency virus. Gairin JE; Madaule P; Traincard F; Barrès E; Rossier J FEMS Microbiol Immunol; 1991 Apr; 3(2):109-19. PubMed ID: 1863470 [TBL] [Abstract][Full Text] [Related]
40. Enhanced expression, secretion, and large-scale purification of recombinant HIV-1 gp120 in insect cell using the baculovirus egt and p67 signal peptides. Murphy CI; McIntire JR; Davis DR; Hodgdon H; Seals JR; Young E Protein Expr Purif; 1993 Oct; 4(5):349-57. PubMed ID: 8251745 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]